Exact Mass: 639.2628182000001

Exact Mass Matches: 639.2628182000001

Found 12 metabolites which its exact mass value is equals to given mass value 639.2628182000001, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

   

5-O-Dimethoxytrityl-N-isobutyryl-deoxyguanosine

5-O-Dimethoxytrityl-N-isobutyryl-deoxyguanosine

C35H37N5O7 (639.2692852)


   

N2-iBu-DMT- dG

Guanosine, 5-O-[bis(4-methoxyphenyl)phenylmethyl]-2-deoxy-N-(2-methyl-1-oxopropyl)-

C35H37N5O7 (639.2692852)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.363 5'-O-DMT-N2-ibu-dG (N2-Isobutyryl-5′-O-(4,4′-dimethoxytrityl)-2′-deoxyguanosine) is a deoxynucleoside which can be used in the preparation of oligonucleotides[1].

   

GalNAcβ1-4[Fucα1-3]GlcNAcβ-Sp

GalNAcβ1-4[Fucα1-3]GlcNAcβ-Sp

C24H41N5O15 (639.2599036)


   

5-O-Dimethoxytrityl-benzoyl-2-deoxyguanosine

5-O-Dimethoxytrityl-benzoyl-2-deoxyguanosine

C35H37N5O7 (639.2692852)


   

25-O-deacetyl-27-O-demethylrifamycin S

25-O-deacetyl-27-O-demethylrifamycin S

C34H41NO11 (639.2679476000001)


   

DTP3 (TFA)

DTP3 (TFA)

C28H36F3N7O7 (639.2628182000001)


DTP3 TFA is a potent and selective GADD45β/MKK7 (growth arrest and DNA-damage-inducible β/mitogen-activated protein kinase kinase 7) inhibitor. DTP3 TFA targets an essential, cancer-selective cell-survival module downstream of the NF-κB pathway[1].

   

n-[2-({2-[(2,4-dicarbamimidamido-3,5,6-trihydroxycyclohexyl)oxy]-4-formyl-4-hydroxy-5-methyloxolan-3-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]-2-hydroxy-n-methylacetamide

n-[2-({2-[(2,4-dicarbamimidamido-3,5,6-trihydroxycyclohexyl)oxy]-4-formyl-4-hydroxy-5-methyloxolan-3-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]-2-hydroxy-n-methylacetamide

C23H41N7O14 (639.2711366000001)


   

n-[(2s,3s,4s,5r,6s)-2-{[(2r,3s,4s,5r)-2-{[(1s,2r,3s,4s,5s,6r)-2,4-dicarbamimidamido-3,5,6-trihydroxycyclohexyl]oxy}-4-formyl-4-hydroxy-5-methyloxolan-3-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]-2-hydroxy-n-methylacetamide

n-[(2s,3s,4s,5r,6s)-2-{[(2r,3s,4s,5r)-2-{[(1s,2r,3s,4s,5s,6r)-2,4-dicarbamimidamido-3,5,6-trihydroxycyclohexyl]oxy}-4-formyl-4-hydroxy-5-methyloxolan-3-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]-2-hydroxy-n-methylacetamide

C23H41N7O14 (639.2711366000001)


   

(1s,2z,16z,18e,20s,21s,22r,23s,24s,25r,28r,29s)-6,8,15,21,23,27,28-heptahydroxy-3,7,20,22,24,29-hexamethyl-26-oxa-14-azatetracyclo[23.2.2.1⁹,¹³.0⁵,¹⁰]triaconta-2,5,7,9,12,14,16,18-octaene-4,11,30-trione

(1s,2z,16z,18e,20s,21s,22r,23s,24s,25r,28r,29s)-6,8,15,21,23,27,28-heptahydroxy-3,7,20,22,24,29-hexamethyl-26-oxa-14-azatetracyclo[23.2.2.1⁹,¹³.0⁵,¹⁰]triaconta-2,5,7,9,12,14,16,18-octaene-4,11,30-trione

C34H41NO11 (639.2679476000001)


   

(1s,2e,16z,18e,20s,21s,22r,23r,24r,25r,28r)-6,8,15,21,23,27,28-heptahydroxy-3,7,16,20,22,24-hexamethyl-26-oxa-14-azatetracyclo[23.2.2.1⁹,¹³.0⁵,¹⁰]triaconta-2,5,7,9,12,14,16,18-octaene-4,11,30-trione

(1s,2e,16z,18e,20s,21s,22r,23r,24r,25r,28r)-6,8,15,21,23,27,28-heptahydroxy-3,7,16,20,22,24-hexamethyl-26-oxa-14-azatetracyclo[23.2.2.1⁹,¹³.0⁵,¹⁰]triaconta-2,5,7,9,12,14,16,18-octaene-4,11,30-trione

C34H41NO11 (639.2679476000001)